Low gamma globulin means your blood contains fewer antibodies than normal, which weakens your body’s ability to fight infections. Gamma globulins are a group of proteins in your blood that function as antibodies, and they include several types: IgG (the most abundant), IgA, IgM, and IgD. A normal total serum globulin level falls between 2.0 and 3.5 g/dL, with IgG alone normally ranging from 800 to 1,600 mg/dL. When these levels drop below normal, the medical term is hypogammaglobulinemia.
What Gamma Globulins Actually Do
Gamma globulins are your immune system’s main weapon against bacteria, viruses, and other invaders. They’re produced by specialized white blood cells called plasma cells. Each type of immunoglobulin plays a different role: IgG handles most of the heavy lifting against infections you’ve encountered before or been vaccinated against, IgA protects the linings of your respiratory and digestive tracts, and IgM is the first responder when your body encounters a new threat.
When gamma globulin levels are low, you lose some or all of this protection. The severity depends on how far below normal your levels fall. Reductions in IgG are classified as mild to moderate (300 to 600 mg/dL), significant (100 to 299 mg/dL), or profoundly reduced (below 100 mg/dL).
How Low Levels Show Up in Daily Life
The hallmark sign is recurring infections, particularly of the sinuses, ears, and lungs. These aren’t the occasional cold that everyone gets. People with low gamma globulin tend to get infections that come back frequently, last longer than expected, or require multiple rounds of antibiotics. Pneumonia, bronchitis, and sinus infections are especially common. Some people also develop chronic diarrhea or other gastrointestinal problems.
Not everyone with low levels experiences symptoms right away. Some people can have significantly reduced antibody levels for years before an environmental trigger, like a viral infection, pushes them into noticeable illness. In some cases, symptoms don’t appear until the seventh or eighth decade of life.
Genetic Causes
Some people are born with immune system defects that prevent normal antibody production. The two most common genetic causes depend on age. In children, the most frequent is X-linked agammaglobulinemia (XLA), a condition caused by a mutation that blocks the development of the cells responsible for making antibodies. Because it’s X-linked, it primarily affects boys.
In adults, the most common inherited cause is common variable immunodeficiency, or CVID. In this condition, the immune cells that should mature into antibody-producing plasma cells don’t develop properly. Roughly 25 to 50% of people with CVID have an identifiable single gene defect, though the specific gene varies from person to person. CVID can be inherited in different patterns and sometimes appears without a clear family history.
Other inherited causes include conditions where only one type of immunoglobulin is missing (selective IgA deficiency being the most common) and transient hypogammaglobulinemia of infancy, where babies have temporarily low levels that improve on their own as their immune system matures.
Acquired Causes
Low gamma globulin can also develop later in life due to other health conditions or treatments. The main acquired causes include:
- Protein loss: Conditions that cause your body to lose protein, such as kidney disease (nephrotic syndrome) or intestinal disorders where protein leaks from the gut (protein-losing enteropathy), can drain your antibody levels.
- Blood cancers: Certain cancers of the blood and immune system, including chronic lymphocytic leukemia and multiple myeloma, can disrupt normal antibody production.
- Medications: Immunosuppressive drugs, corticosteroids, and chemotherapy can all suppress antibody production as a side effect. This is one of the more common reasons for low levels in people who were previously healthy.
- Malabsorption: Conditions that prevent proper nutrient absorption in the gut can contribute to low protein and antibody levels.
What Happens If It Goes Untreated
Left unaddressed, persistently low gamma globulin levels put you at risk for serious infections including pneumonia, meningitis, and bloodstream infections. But the long-term damage goes beyond individual infections. Repeated lung infections can cause bronchiectasis, a permanent widening and scarring of the airways that makes future infections even more likely and harder to treat. Studies of untreated patients with CVID have found bronchiectasis to be one of the most common complications. Some patients also develop autoimmune and inflammatory conditions, where the already-dysfunctional immune system begins attacking the body’s own tissues.
How It’s Diagnosed
A low gamma globulin level on a standard blood test (serum protein electrophoresis) is the starting point, but it’s not the whole picture. The next step is measuring individual immunoglobulin levels: IgG, IgA, and IgM. Normal reference ranges for adults are roughly 800 to 1,600 mg/dL for IgG, 40 to 220 mg/dL for IgA, and 120 to 400 mg/dL for IgM, though exact ranges vary slightly between labs.
If IgG falls between 150 and 600 mg/dL, your doctor may check how well your immune system responds to vaccines. This involves measuring your antibody levels against common vaccines like tetanus and diphtheria. If your body can’t mount a normal antibody response to these challenges, that’s a stronger indicator of a real immune deficiency rather than a lab quirk. Levels at or below 150 mg/dL are considered severe and typically point clearly toward a need for treatment.
Treatment and What to Expect
When low gamma globulin is caused by another condition or medication, treating the underlying problem or adjusting the medication may restore antibody levels. For people with genetic immune deficiencies, immunoglobulin replacement therapy is the primary treatment. This means receiving purified antibodies from donor blood to bring your levels back to a protective range.
There are two ways to receive replacement therapy. Intravenous infusions (IVIG) are given in a clinic or hospital, typically every three to four weeks. They deliver a larger dose at once, producing higher peak antibody levels that gradually decline until the next infusion. Subcutaneous infusions (SCIG) use a smaller dose, usually 100 to 200 mg per kilogram of body weight, given every one to two weeks. The subcutaneous route involves a small volume of fluid (on average 20 to 60 mL per session) injected just under the skin, and most people learn to do it at home. SCIG tends to maintain steadier antibody levels between doses and is often better tolerated, with fewer systemic side effects.
The choice between the two comes down to lifestyle, vein access, and how your body responds. Some people prefer the convenience of less frequent clinic visits with IVIG, while others prefer the independence and stability of home-based SCIG. Both approaches effectively reduce the frequency and severity of infections in people with confirmed antibody deficiencies.